Person

Jon Coleman

EVP, Chief Commercial Officer, Dexcom

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$723K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • DXCM
    Dexcom
    EVP, Chief Commercial Officer
    since Mar 2025

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 4, 2026DXCMSale4,911$74.13$364K
Jun 3, 2026DXCMSale4,912$73.00$359K

SEC reporting-owner ID (CIK) 1442689 · all filings on EDGAR